Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.03%
#2 aelf aelf +33.32%
#3 Bitway Bitway +28.63%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.90%
#5 Starpower Starpower +20.64%
#6 Pons Pons +20.39%
#7 Decred Decred +14.50%
#8 PondCoin PondCoin +10.24%
#9 Talus Network Talus Network +9.61%
#10 MarsCoin MarsCoin +8.21%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
設定
言語
日本
通貨
USD
テーマ
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
株式のランク #30195
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
株価
$0.22227521
時価総額
$17.81M
変化（1日）
0.00%
変化（1年）
-14.81%
国
TW
取引 TaiwanJ Pharmaceuticals Co., Ltd. (6549)

カテゴリー

Healthcare
TaiwanJ Pharmaceuticals Co., Ltd.（6549）の利益
2026 時点の利益 TTM: 0
TaiwanJ Pharmaceuticals Co., Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
TaiwanJ Pharmaceuticals Co., Ltd. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE